KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Goodwill & Intangibles: 2009-2021

Historic Goodwill & Intangibles for Ionis Pharmaceuticals (IONS) over the last 13 years, with Dec 2021 value amounting to $29.0 million.

  • Ionis Pharmaceuticals' Goodwill & Intangibles fell 1.44% to $29.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $29.6 million, marking a year-over-year decrease of 1.44%. This contributed to the annual value of $29.0 million for FY2021, which is 3.82% up from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Goodwill & Intangibles of $29.0 million as of FY2021, which was up 3.82% from $27.9 million recorded in FY2020.
  • In the past 5 years, Ionis Pharmaceuticals' Goodwill & Intangibles ranged from a high of $29.0 million in FY2021 and a low of $22.0 million during FY2017.
  • In the last 3 years, Ionis Pharmaceuticals' Goodwill & Intangibles had a median value of $27.9 million in 2020 and averaged $27.5 million.
  • Data for Ionis Pharmaceuticals' Goodwill & Intangibles shows a peak YoY increased of 9.22% (in 2018) over the last 5 years.
  • Over the past 5 years, Ionis Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $22.0 million in 2017, then grew by 9.22% to $24.0 million in 2018, then increased by 6.83% to $25.7 million in 2019, then rose by 8.81% to $27.9 million in 2020, then climbed by 3.82% to $29.0 million in 2021.